Monthly Archives: November 2015

Minneapolis / St. Paul television station KARE 11 recently published an investigative report on the tactics of the PBMs. This, coupled with the recent testimony heard at the House Judiciary Committee’s hearings cast a poor light on the industry. Click here to read an interesting report....
Continue Reading →
Recently I have been in a discussion about several 2016 Medicare Part D plan that are appearing at the top of the savings lists when comparing plans with Medicare.gov and iMedicare.com (a third party plan comparison tool using the Medicare information). The issue we are regularly seeing is generics being listed around $1.00 per month. That......
Continue Reading →
AccessRx has published an excellent overview of the House Judiciary’s PBM Hearing. Click here to read their summary and analysis....
Continue Reading →
It is becoming increasingly evident that the current Medicare pharmacy benefit (Medicare Part D) is broken. Recently, several Medicare Prescription Drug Plans (PDPs) were given the opportunity to hear about pharmacists’ activities to support clinical outcomes and patient care. The information presented included a description of significant savings a commercial plan realized due to the positive effects of......
Continue Reading →
Some time back I wrote about “The Rewards of Performance“. In that piece, I discussed the existence of Generic Dispensing Rates (GPR) as one of the measures used by a plan to “reward” a pharmacy for clinical performance. Since that time, several additional plans have announced their 2016 Prescription Drug Plans, and several have a......
Continue Reading →